These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Annexin A5 anticoagulant activity in children with systemic lupus erythematosus and the association with antibodies to domain I of β2-glycoprotein I. Wahezi DM; Ilowite NT; Wu XX; Pelkmans L; Laat B; Schanberg LE; Rand JH; Lupus; 2013 Jun; 22(7):702-11. PubMed ID: 23690366 [TBL] [Abstract][Full Text] [Related]
4. Annexin-A5 resistance and non-criteria antibodies for the diagnosis of seronegative antiphospholipid syndrome. Ferreira TG; Delhommeau F; Johanet C; Gerotziafas G; Bornes M; Cohen J; Kayem G; Fain O; Planche V; Mékinian A Clin Rheumatol; 2020 Apr; 39(4):1167-1171. PubMed ID: 31925628 [TBL] [Abstract][Full Text] [Related]
5. Association of silent infarcts in sickle cell anemia with decreased annexin A5 resistance. Morrone KA; Pecker LH; Rand J; Davila J; Oyeku S; Little JA; Xiaonan X; Manwani D Blood Cells Mol Dis; 2018 Mar; 69():53-56. PubMed ID: 28911832 [TBL] [Abstract][Full Text] [Related]
6. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Von Landenberg P; Lehmann HW; Knöll A; Dorsch S; Modrow S Arthritis Rheum; 2003 Jul; 48(7):1939-47. PubMed ID: 12847688 [TBL] [Abstract][Full Text] [Related]
7. Annexin A5 polymorphism (-1C-->T) and the presence of anti-annexin A5 antibodies in the antiphospholipid syndrome. de Laat B; Derksen RH; Mackie IJ; Roest M; Schoormans S; Woodhams BJ; de Groot PG; van Heerde WL Ann Rheum Dis; 2006 Nov; 65(11):1468-72. PubMed ID: 16449315 [TBL] [Abstract][Full Text] [Related]
8. Human monoclonal antiphospholipid antibodies disrupt the annexin A5 anticoagulant crystal shield on phospholipid bilayers: evidence from atomic force microscopy and functional assay. Rand JH; Wu XX; Quinn AS; Chen PP; McCrae KR; Bovill EG; Taatjes DJ Am J Pathol; 2003 Sep; 163(3):1193-200. PubMed ID: 12937161 [TBL] [Abstract][Full Text] [Related]
10. Detection of complement-fixing antiphospholipid antibodies in association with thrombosis. Munakata Y; Saito T; Matsuda K; Seino J; Shibata S; Sasaki T Thromb Haemost; 2000 May; 83(5):728-31. PubMed ID: 10823270 [TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: a thrombogenic mechanism for the antiphospholipid syndrome. Rand JH J Autoimmun; 2000 Sep; 15(2):107-11. PubMed ID: 10968894 [TBL] [Abstract][Full Text] [Related]
12. Detection of antibody-mediated reduction of annexin A5 anticoagulant activity in plasmas of patients with the antiphospholipid syndrome. Rand JH; Wu XX; Lapinski R; van Heerde WL; Reutelingsperger CP; Chen PP; Ortel TL Blood; 2004 Nov; 104(9):2783-90. PubMed ID: 15242878 [TBL] [Abstract][Full Text] [Related]
13. The annexin A5-mediated pathogenic mechanism in the antiphospholipid syndrome: role in pregnancy losses and thrombosis. Rand JH; Wu XX; Quinn AS; Taatjes DJ Lupus; 2010 Apr; 19(4):460-9. PubMed ID: 20353989 [TBL] [Abstract][Full Text] [Related]
14. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. Tomás JF; Alberca I; Tabernero MD; Cordero M; Del Pino-Montes J; Vicente V J Rheumatol; 1998 Jan; 25(1):57-62. PubMed ID: 9458203 [TBL] [Abstract][Full Text] [Related]
15. The geoepidemiology of the antiphospholipid antibody syndrome. Biggioggero M; Meroni PL Autoimmun Rev; 2010 Mar; 9(5):A299-304. PubMed ID: 19932199 [TBL] [Abstract][Full Text] [Related]
16. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Tektonidou MG; Laskari K; Panagiotakos DB; Moutsopoulos HM Arthritis Rheum; 2009 Jan; 61(1):29-36. PubMed ID: 19116963 [TBL] [Abstract][Full Text] [Related]
17. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests. Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167 [TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of antiphospholipid antibodies in Syrian patients with thrombosis. Deeb A; Hamdoun S; Dababo K Iran J Immunol; 2009 Sep; 6(3):154-9. PubMed ID: 19801789 [TBL] [Abstract][Full Text] [Related]
20. [Antiphospholipid antibodies and recurrent abortions: possible pathogenetic role of annexin A5 investigated by confocal microscopy]. Peluso G; Morrone G Minerva Ginecol; 2007 Jun; 59(3):223-9. PubMed ID: 17576401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]